BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21295814)

  • 1. Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants.
    Edo-Matas D; van Dort KA; Setiawan LC; Schuitemaker H; Kootstra NA
    Virology; 2011 Apr; 412(2):269-77. PubMed ID: 21295814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
    Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.
    Edo-Matas D; Rachinger A; Setiawan LC; Boeser-Nunnink BD; van 't Wout AB; Lemey P; Schuitemaker H
    Virology; 2012 Jan; 422(1):70-80. PubMed ID: 22047989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.
    Mild M; Esbjörnsson J; Fenyö EM; Medstrand P
    J Virol; 2007 Apr; 81(7):3369-76. PubMed ID: 17251288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
    Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR
    Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.
    Coetzer M; Cilliers T; Ping LH; Swanstrom R; Morris L
    Virology; 2006 Dec 5-20; 356(1-2):95-105. PubMed ID: 16942785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
    Huang W; Eshleman SH; Toma J; Fransen S; Stawiski E; Paxinos EE; Whitcomb JM; Young AM; Donnell D; Mmiro F; Musoke P; Guay LA; Jackson JB; Parkin NT; Petropoulos CJ
    J Virol; 2007 Aug; 81(15):7885-93. PubMed ID: 17507467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
    Bunnik EM; Quakkelaar ED; van Nuenen AC; Boeser-Nunnink B; Schuitemaker H
    J Virol; 2007 Jan; 81(2):525-31. PubMed ID: 17079299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
    J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
    Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
    Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
    Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
    Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
    Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
    J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.
    Xiao L; Owen SM; Goldman I; Lal AA; deJong JJ; Goudsmit J; Lal RB
    Virology; 1998 Jan; 240(1):83-92. PubMed ID: 9448692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 clade C env clones obtained from an Indian patient exhibiting expanded coreceptor tropism are presented with naturally occurring unusual amino acid substitutions in V3 loop.
    Gharu L; Ringe R; Pandey S; Paranjape R; Bhattacharya J
    Virus Res; 2009 Sep; 144(1-2):306-14. PubMed ID: 19409946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.
    Ogert RA; Lee MK; Ross W; Buckler-White A; Martin MA; Cho MW
    J Virol; 2001 Jul; 75(13):5998-6006. PubMed ID: 11390601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J; Barretina J; Clotet B; Esté JA
    J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.